Perrigo (PRGO) Change in Taxes (2013 - 2026)
Perrigo (PRGO) posted quarterly Change in Taxes of -$13.2 million for Q1 2026, down 466.67% year-over-year from $3.6 million in Q1 2025, and down 112.3% quarter-over-quarter from $107.3 million in Q4 2025.
Perrigo (PRGO) Change in Taxes (2013 - 2026) Analysis & Trends
Perrigo (PRGO) has reported Change in Taxes for 14 consecutive years, with -$13.2 million the latest figure, recorded in Q1 2026.
- In Q1 2026, Change in Taxes fell 466.67% year-over-year to -$13.2 million; the TTM figure through Mar 2026 stood at $39.1 million (down 26.78% YoY), while the FY2025 annual figure was $55.9 million, up 275.79% from the prior year.
- Change in Taxes retreated to -$13.2 million in Q1 2026 per PRGO's latest filing, from $107.3 million in the prior quarter.
- Across five years, Change in Taxes topped out at $107.3 million in Q4 2025 and bottomed at -$81.6 million in Q1 2024.
- Historically, Change in Taxes has averaged -$2.9 million across 5 years, with a median of -$3.8 million in 2024.
- Annual changes were most pronounced in 2023 — Change in Taxes surged 1786.36% — and 2024, when it plunged 3364.0%.
- Perrigo's Change in Taxes stood at $2.2 million in 2022, then soared by 1786.36% to $41.5 million in 2023, then jumped by 147.71% to $102.8 million in 2024, then rose by 4.38% to $107.3 million in 2025, then tumbled by 112.3% to -$13.2 million in 2026.
- Business Quant data shows PRGO's Change in Taxes at -$13.2 million in Q1 2026, $107.3 million in Q4 2025, and $3.1 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Taxes (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 44.51 Bn | 43.55 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 43.52 Bn | 39.86 Bn | 2.15 Bn | - |
| 3 | Zoetis | 32.43 Bn | 30.75 Bn | 1.05 Bn | -66.00 Mn |
| 4 | Takeda Pharmaceutical | 28.63 Bn | 22.83 Bn | 5.10 Bn | -106.03 Mn |
| 5 | United Therapeutics | 21.87 Bn | 19.21 Bn | 683.80 Mn | - |
| 6 | Viatris | 18.98 Bn | 18.09 Bn | 1.46 Bn | 40.90 Mn |
| 7 | Neurocrine Biosciences | 15.43 Bn | 15.04 Bn | 935.80 Mn | -59.60 Mn |
| 8 | Elanco Animal Health | 12.02 Bn | 11.49 Bn | 798.00 Mn | - |
| 9 | Dr Reddys Laboratories | 10.14 Bn | 9.98 Bn | - | - |
| 10 | Perrigo | 1.98 Bn | 1.58 Bn | 313.90 Mn | -200,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 27, 2026 | -200,000.00 |
| Jun 27, 2026 | -200,000.00 |
| Mar 28, 2026 | -13.20 Mn |
| Mar 28, 2026 | -13.20 Mn |
| Dec 31, 2025 | 107.30 Mn |
| Dec 31, 2025 | 107.30 Mn |
| Sep 27, 2025 | 3.10 Mn |
| Sep 27, 2025 | 3.10 Mn |
| Jun 28, 2025 | -58.10 Mn |
| Jun 28, 2025 | -58.10 Mn |
| Mar 29, 2025 | 3.60 Mn |
| Mar 29, 2025 | 3.60 Mn |
| Dec 31, 2024 | 102.80 Mn |
| Dec 31, 2024 | 102.80 Mn |
| Sep 28, 2024 | -3.80 Mn |
| Sep 28, 2024 | -3.80 Mn |
| Jun 29, 2024 | -49.20 Mn |
| Jun 29, 2024 | -49.20 Mn |
| Mar 30, 2024 | -81.60 Mn |
| Mar 30, 2024 | -81.60 Mn |